Transmagnetic Stimulation Pilot in Early Stage Alzheimer's Disease
Launched by HEALTHPARTNERS INSTITUTE · Mar 14, 2022
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Established diagnosis of Mild Cognitive Impairment (MCI)/mild AD
- • Evidence for Central Nervous System (CNS) amyloidosis (e.g., Amyloid positron emission tomography (PET) or cerebrospinal fluid (CSF) biomarkers consistent with AD)
- • Prior brain imaging performed
- • Mini-Mental State Examination (MMSE) \>24
- • Clinical Dementia Rating (CDR) Scale 0.5-1
- • Stable dose of cholinesterase inhibitors and memantine for at least one month
- • Subjects are between 40-90 years of age
- Exclusion Criteria:
- • Non-AD dementia including, but not limited to, Lewy body dementia, frontotemporal dementia, vascular dementia, Jakob-Creutzfeldt disease, etc.
- • Inability to tolerate rs-fMRI
- • Contraindication of rs-fMRI due to implants or metal
- • Seizure disorder
About Healthpartners Institute
HealthPartners Institute is a leading research organization affiliated with HealthPartners, a prominent not-for-profit healthcare provider in the United States. Dedicated to advancing health outcomes and improving patient care, the Institute conducts innovative clinical trials across various medical disciplines, with a focus on translating research findings into practical applications. By fostering collaboration among healthcare professionals, researchers, and patients, HealthPartners Institute aims to enhance evidence-based practices and contribute to the development of new treatments and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Paul, Minnesota, United States
Patients applied
Trial Officials
Bhavani Kashyap, MBBS, PhD
Principal Investigator
HealthPartners Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials